Filing Flows › LifeMD (LFMD) › Q4 2025
LifeMD (LFMD) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 10, 2026
LifeMD (LFMD) reported revenue of $7.1M for the fourth quarter 2025 (Q4 2025), +29% from a year earlier and -88% from the quarter before. Operating margin was -87.9%, net earnings $19.9M (281.7% of revenue).
LifeMD, Q4 2025: revenue $7.1M (+29% year over year), operating margin -87.9%, net earnings $19.9M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.1M | -88% | +29% |
| Operating profit | −$6.2M | — | -711% |
| Net earnings | $19.9M | — | 85× |
| Operating cash flow | −$3.3M | — | -406% |
What changed
Revenue was $7.1M in Q4 2025, up 29% year over year and down 88% from the previous quarter.
Gross margin was 40.2%. Operating costs exceeded revenue by $6.2M, an operating margin of -87.9%. Net earnings were $20.0M ($19.9M including minority interests, which bore $21K of losses). The effective tax rate was -0.6%. Non-operating items added $26.0M, 131% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$3.3M. Non-cash charges added back $2.7M of share-based compensation. Working capital and other items used $25.9M. Capital expenditures of $155K exceeded it, leaving free cash flow of −$3.4M.
Questions
What was LifeMD's revenue in the fourth quarter 2025?
LifeMD (LFMD) reported revenue of $7.1M for the fourth quarter 2025 (Q4 2025), +29% from a year earlier and -88% from the quarter before.
Was LifeMD profitable in the fourth quarter 2025?
Operating loss was $6.2M (-87.9% of revenue) and net earnings $19.9M.
Source: LifeMD 10-K on SEC EDGAR.